Related references
Note: Only part of the references are listed.Retroviral integrations contribute to elevated host cancer rates during germline invasion
Gayle K. McEwen et al.
NATURE COMMUNICATIONS (2021)
Insights Into Host Cell Cytokines in Chlamydia Infection
Wenjing Xiang et al.
FRONTIERS IN IMMUNOLOGY (2021)
A proposed roadmap for the control of infections in wildlife using Chlamydia vaccine development in koalas Phascolarctos cinereus as a template
Courtney A. Waugh et al.
WILDLIFE BIOLOGY (2020)
Therapeutic vaccination of koalas harbouring endogenous koala retrovirus (KoRV) improves antibody responses and reduces circulating viral load
Olusola Olagoke et al.
NPJ VACCINES (2020)
Vaccination of koalas during antibiotic treatment for Chlamydia-induced cystitis induces an improved antibody response to Chlamydia pecorum
Samuel Phillips et al.
SCIENTIFIC REPORTS (2020)
Koalas vaccinated against Koala retrovirus respond by producing increased levels of interferon-gamma
Olusola Olagoke et al.
VIROLOGY JOURNAL (2020)
Altered immune parameters associated with Koala Retrovirus (KoRV) and Chlamydial infection in free ranging Victorian koalas (Phascolarctos cinereus)
Iona E. Maher et al.
SCIENTIFIC REPORTS (2019)
Antibody response against koala retrovirus (KoRV) in koalas harboring KoRV-A in the presence or absence of KoRV-B
O. Olagoke et al.
SCIENTIFIC REPORTS (2019)
Longitudinal study of wild koalas (Phascolarctos cinereus) reveals chlamydial disease progression in two thirds of infected animals
Amy Robbins et al.
SCIENTIFIC REPORTS (2019)
Therapeutic effect of a Chlamydia pecorum recombinant major outer membrane protein vaccine on ocular disease in koalas (Phascolarctos cinereus)
Sharon Nyari et al.
PLOS ONE (2019)
Molecular Dynamics and Mode of Transmission of Koala Retrovirus as It Invades and Spreads through a Wild Queensland Koala Population
Bonnie L. Quigley et al.
JOURNAL OF VIROLOGY (2018)
Vaccination of koalas (Phascolarctos cinereus) against Chlamydia pecorum using synthetic peptides derived from the major outer membrane protein
Sharon Nyari et al.
PLOS ONE (2018)
Induction of neutralizing antibody response against koala retrovirus (KoRV) and reduction in viral load in koalas following vaccination with recombinant KoRV envelope protein
O. Olagoke et al.
NPJ VACCINES (2018)
Immunization of a wild koala population with a recombinant Chlamydia pecorum Major Outer Membrane Protein (MOMP) or Polymorphic Membrane Protein (PMP) based vaccine: New insights into immune response, protection and clearance
Marion Desclozeaux et al.
PLOS ONE (2017)
Epidemiology of chlamydial infection and disease in a free-ranging koala (Phascolarctos cinereus) population
Sharon Nyari et al.
PLOS ONE (2017)
Treatment of Chlamydia-associated ocular disease via a recombinant protein based vaccine in the koala (Phascolarctos cinereus)
Courtney Waugh et al.
BIOLOGICALS (2016)
Humoral immune responses in koalas (Phascolarctos cinereus) either naturally infected with Chlamydia pecorum or following administration of a recombinant chlamydial major outer membrane protein vaccine
Shahneaz Ali Khan et al.
VACCINE (2016)
A Prototype Recombinant-Protein Based Chlamydia pecorum Vaccine Results in Reduced Chlamydial Burden and Less Clinical Disease in Free-Ranging Koalas (Phascolarctos cinereus)
Courtney Waugh et al.
PLOS ONE (2016)
Antibody and Cytokine Responses of Koalas (Phascolarctos cinereus) Vaccinated with Recombinant Chlamydial Major Outer Membrane Protein (MOMP) with Two Different Adjuvants
Shahneaz Ali Khan et al.
PLOS ONE (2016)
Altered Immune Cytokine Expression Associated with KoRV B Infection and Season in Captive Koalas
Iona E. Maher et al.
PLOS ONE (2016)
A re-evaluation of the role of B cells in protective immunity to Chlamydia infection
Lin-Xi Li et al.
IMMUNOLOGY LETTERS (2015)
Seminal Levels of IL-10, IL-12, and IL-17 in Men with Asymptomatic Chlamydia Infection
Hamid Hakimi et al.
INFLAMMATION (2014)
Vaccination of koalas (Phascolarctos cinereus) with a recombinant chlamydial major outer membrane protein adjuvanted with poly I:C, a host defense peptide and polyphosphazine, elicits strong and long lasting cellular and humoral immune responses
Shahneaz Ali Khan et al.
VACCINE (2014)
Vaccination of Koalas with a Recombinant Chlamydia pecorum Major Outer Membrane Protein Induces Antibodies of Different Specificity Compared to Those Following a Natural Live Infection
Avinash Kollipara et al.
PLOS ONE (2013)
An exogenous retrovirus isolated from koalas with malignant neoplasias in a US zoo
Wenqin Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Antigenic specificity of a monovalent versus polyvalent MOMP based Chlamydia pecorum vaccine in koalas (Phascolarctos cinereus)
Avinash Kollipara et al.
VACCINE (2013)
IL-17A Synergizes with IFN-γ to Upregulate iNOS and NO Production and Inhibit Chlamydial Growth
Yongci Zhang et al.
PLOS ONE (2012)
Vaccination of healthy and diseased koalas (Phascolarctos cinereus) with a Chlamydia pecorum multi-subunit vaccine: Evaluation of immunity and pathology
Avinash Kollipara et al.
VACCINE (2012)
Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae
Antonietta Rizzo et al.
CYTOKINE (2011)
Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis
Shabaana A. Khader et al.
VIRULENCE (2010)
IL-17/Th17 Promotes Type 1 T Cell Immunity against Pulmonary Intracellular Bacterial Infection through Modulating Dendritic Cell Function
Hong Bai et al.
JOURNAL OF IMMUNOLOGY (2009)
Digital mRNA profiling
Paolo Fortina et al.
NATURE BIOTECHNOLOGY (2008)
Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells
M Johansson et al.
IMMUNOLOGY (2001)
Share Paper
